STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
90
13F, latest reported quarter
What the filings say about CBAN
Insiders, 180 days
+$170.9K net bought
1 buyer
Colony Bankcorp insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, COLONY BANKCORP INC insiders bought a net $170.9K of stock across 109 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CBAN planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CBAN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Regional Bank Fund
$3.8M position · as of 2026-07-31
0.4%
Victory Target Managed Allocation Fund
$568.5K position · as of 2026-05-31
0.3%
Ultra-Small Company Market Fund
$455.6K position · as of 2026-06-30
0.3%
Adara Smaller Companies Fund
$2.5M position · as of 2026-05-31
0.3%
NORTH SQUARE DYNAMIC SMALL CAP FUND
$1.7M position · as of 2026-05-31
0.2%
Innovator U.S. Small Cap Managed Floor ETF
$150.3K position · as of 2026-07-31
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Fountain
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.0M
$1.0M
$551.0K
+10%
n/a
2024
$956.2K
$998.9K
$515.4K
+21%
n/a
2023
$623.6K
$627.0K
$375.8K
+5%
n/a
2022
$692.6K
$650.5K
$501.8K
-25%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $170.9K bought by insiders over 180 days, 90 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CBAN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CBAN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$21.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CBAN
FY Dec 2025
-$6.9M
FY Dec 2024
$22.3M
FY Dec 2023
$17.4M
FY Dec 2022
$46.8M
FY Dec 2021
$30.3M
Jun 2026
$8.2M
Mar 2026
$53.8M
Dec 2025
-$54.3M
Sep 2025
$14.1M
Jun 2025
$15.8M
Mar 2025
$17.6M
Dec 2024
-$3.8M
Sep 2024
$20.2M
At each fiscal year end
Single quarter
Debt to equity
0.66x
long-term debt only, 2025-12-31 (6 months older than the period end); equity 2026-06-30
Debt to equity CBAN
FY Dec 2025
0.69x
FY Dec 2024
0.89x
FY Dec 2023
0.94x
FY Dec 2022
0.88x
FY Dec 2021
0.41x
Jun 2026
0.66x
Mar 2026
0.68x
Dec 2025
0.69x
Sep 2025
0.82x
Jun 2025
0.84x
Mar 2025
0.86x
Dec 2024
0.89x
Sep 2024
0.86x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.09x
TTM operating cash flow over long-term debt only, 2025-12-31 (6 months older than the period end)
Cash flow to debt CBAN
FY Dec 2025
-0.02x
FY Dec 2024
0.09x
FY Dec 2023
0.09x
FY Dec 2022
0.24x
FY Dec 2021
0.41x
Jun 2026
0.09x
Mar 2026
0.12x
Dec 2025
-0.02x
Sep 2025
0.18x
Jun 2025
0.21x
Mar 2025
0.15x
Dec 2024
0.09x
Sep 2024
0.14x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+3.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CBAN
FY Dec 2025
+2.0%
FY Dec 2024
+8.9%
FY Dec 2023
+9.0%
FY Dec 2022
+8.7%
FY Dec 2021
+10.3%
Jun 2026
+3.2%
Mar 2026
+2.5%
Dec 2025
+2.0%
Sep 2025
+9.6%
Jun 2025
+9.9%
Mar 2025
+9.2%
Dec 2024
+8.9%
Sep 2024
+8.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CBAN
FY Dec 2025
+0.2%
FY Dec 2024
+0.8%
FY Dec 2023
+0.7%
FY Dec 2022
+0.7%
FY Dec 2021
+0.8%
Jun 2026
+0.3%
Mar 2026
+0.2%
Dec 2025
+0.2%
Sep 2025
+0.9%
Jun 2025
+0.9%
Mar 2025
+0.8%
Dec 2024
+0.8%
Sep 2024
+0.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CBAN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CBAN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
46.36x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CBAN
FY Dec 2025
46.89x
FY Dec 2024
11.96x
FY Dec 2023
10.73x
FY Dec 2022
11.03x
FY Dec 2021
10.28x
Jun 2026
45.66x
Mar 2026
51.21x
Dec 2025
46.89x
Sep 2025
10.70x
Jun 2025
10.42x
Mar 2025
11.29x
Dec 2024
11.96x
Sep 2024
12.42x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$586.9M
market value at close 2026-10-27 on 2026-08-03 shares, plus long-term debt only, 2025-12-31 (6 months older than the period end), minus cash 2019-12-31
Enterprise value CBAN
FY Dec 2025
$464.7M
FY Dec 2024
$426.8M
FY Dec 2023
$368.0M
FY Dec 2022
$323.1M
FY Dec 2021
$217.8M
Jun 2026
$579.1M
Mar 2026
$576.7M
Dec 2025
$464.7M
Sep 2025
$441.0M
Jun 2025
$431.2M
Mar 2025
$426.9M
Dec 2024
$426.8M
Sep 2024
$407.3M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.0%
TTM free cash flow over market value at close 2026-10-27
FCF yield CBAN
FY Dec 2025
-2.2%
FY Dec 2024
+7.9%
FY Dec 2023
+7.4%
FY Dec 2022
+20.9%
FY Dec 2021
+13.0%
Jun 2026
+5.1%
Mar 2026
+6.9%
Dec 2025
-2.2%
Sep 2025
+14.7%
Jun 2025
+17.3%
Mar 2025
+12.4%
Dec 2024
+7.9%
Sep 2024
+11.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -72%, PEG needs growth
PEG, trailing CBAN
FY Dec 2025
n/a
FY Dec 2024
1.35x
FY Dec 2023
1.37x
FY Dec 2022
n/a
FY Dec 2021
0.30x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
0.39x
Jun 2025
0.41x
Mar 2025
0.78x
Dec 2024
1.35x
Sep 2024
15.40x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CBAN ranks highest on insider conviction (67th percentile) and institutional and government (46th), and lowest on profitability (13th), among Banks peers.
Profitability
13
Inputs
Return on equity+3.2% · 14 pct, sector of 327
Return on assets+0.3% · 13 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
16
Inputs
Debt to equity0.66x · 21 pct, sector of 229
Cash flow to debt0.09x · 11 pct, sector of 198
Insider conviction
67
Inputs
Net Form 4 buying (codes P and S), 180d$171K · 88 pct, sector of 274
Insider buyers, 180d1 · 46 pct, sector of 274
Institutional and government
46
Inputs
Funds adding, latest quarter90 · 46 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
15
Inputs
Short interest, % of float+6.7% · 15 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Growth, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CBAN filings, in plain words
Are Colony Bankcorp insiders buying or selling CBAN?
In the 180 days to 2026-10-28, Colony Bankcorp insiders were net buyers, a net $170.9K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-28, Colony Bankcorp insiders were net buyers of CBAN, a net $170.9K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.